Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

116.05 +2.27 (+2.00%)
Streaming Delayed Price Updated: 10:28 AM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ICON plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
ICON expands US early phase research capabilities with new clinic and outpatient centres
From ICON plc
Via Business Wire
News headline image
ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results
From ICON plc
Via Business Wire
News headline image
ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model
From ICON plc
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICON plc – ICLR
From Pomerantz LLP
Via GlobeNewswire
News headline image
Ademi LLP Investigates Claims of Securities Fraud against ICON plc
From Ademi LLP
Via GlobeNewswire
News headline image
ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
ICLR INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ICON Public Limited Company
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICON plc - ICLR
From Pomerantz LLP
Via GlobeNewswire
News headline image
ICLR SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating ICON plc on Behalf of ICON Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ICON PUBLIC LIMITED COMPANY INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
From Kirby McInerney LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into ICON Public Limited Company (ICLR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
ICON Public Limited Company (ICLR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into ICON Public Limited Company (ICLR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Rosen Law Firm Encourages ICON plc Investors to Inquire About Securities Class Action Investigation – ICLR
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices
From ICON plc
Via Business Wire
News headline image
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
From ICON plc
Via Business Wire
News headline image
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
From ICON plc
Via Business Wire
News headline image
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
From ICON plc
Via Business Wire
News headline image
ICON plc to Present at the Jefferies London Healthcare Conference
From ICON plc
Via Business Wire
News headline image
ICON Reports Third Quarter 2025 Results
From ICON plc
Via Business Wire
News headline image
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
News headline image
ICON Announces CEO Transition
From ICON plc
Via Business Wire
News headline image
ICON plc to Participate at Upcoming Investor Conferences
From ICON plc
Via Business Wire
News headline image
ICON Announces Results of Annual General Meeting
From ICON plc
Via Business Wire
News headline image
ICON Reports Second Quarter 2025 Results
From ICON plc
Via Business Wire
News headline image
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
From ICON plc
Via Business Wire
News headline image
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
From ICON plc
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.